A Phase II, Randomised, Double-Blind, Placebo-Controlled Pilot Efficacy Study of ADC4022 on Markers of Pulmonary Inflammation in Subjects With Moderate to Severe COPD.
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2011
At a glance
- Drugs Theophylline (Primary) ; Budesonide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 06 Oct 2009 Results were presented at the 19th Annual Congress of the European Respiratory Society, 12 Sep 2009.
- 27 Feb 2009 Actual patient numbers (91) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History